Enerzair Breezhaler

· Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enerzair Breezhaler, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: EMA Authorised: Enerzair Breezhaler (indacaterol;glycopyrronium bromide;mometasone) — Novartis Europharm Limited